(PharmaNewsWire.Com, April 12, 2022 ) The North America Scar Treatment Market is bound to grow robustly in the years to come. With smart technology and 5G being increasingly adopted, the healthcare vertical is witnessing a paradigm shift. These technologies can thus increase the convenience quotient (CQ), as abysmal disruption happens in the patients’ lives. This convenience quotient would be the trend running in the healthcare vertical shortly.
The North America scar treatment market is valued at US$ 3.8 Bn, and is expected to progress at a sluggish CAGR of 2.2% to attain a valuation of approximately US$ 4.7 Bn by the end of 2031.
Scars are visible marks that remain after a wound has healed and is normally composed of fibrous tissue. Scar revision is a surgical procedure used to remove or reduce scars. This procedure also helps to restore functions such as skin maturations and collagen production and corrects changes caused to the skin by wounds or even surgery.
The report analyzes the North America scar treatment market in terms of market value (US$ Mn) on the basis of treatment, product type, distribution channel, and country. It also provides information regarding market dynamics, value chain, competitive landscape, current trends, market estimations, and forecast.
North America is expected to be the dominant region in the global scar treatment market throughout the forecast period, driven by increasing number of trauma cases, burn-related surgeries etc.
Smith & Nephew Inc. Merz Inc. Enaltus LLC. Oculus Innovative Sciences, Inc. CCA Industries, Cynosure, Inc. Avita Medical. LUTRONIC. Luminus Inc. Syneron Medical Ltd. NutraMarks, Inc.
The market in the U.S. is currently dominant in terms of revenue contribution to the North America scar treatment market.
Rising number of trauma and burn cases, increasing demand for minimally invasive surgeries coupled with effective scar treatment procedures such as laser treatment, rising awareness regarding personal care, and desire to remain beautiful are factors expected to boost the overall demand for scar treatment products in the North America scar treatment market in the near future.
By treatment, the North America scar treatment market is segmented into topical treatment, laser treatment, surface treatment, and injections. Among these, the topical treatment segment is expected to dominate the overall market by 2022, owing to ease of use, low price, lesser side effects associated with the treatment which includes skin rashes, hyperpigmentation and skin redness and easy availability.
By product type, the North America scar treatment market is segmented into topical products, laser treatment products, surface treatment, and injectable. Topical product segment is further sub-segmented into gels, creams, oils, and sheets. The segment is projected to register above average growth rate over the forecast period. However, laser treatment product type segment is estimated to register highest CAGR in the North America scar treatment market over the forecast period.
By distribution channel, North America scar treatment market is segmented into hospitals, clinics, pharmacies and drug stores, and e-Commerce. Among these, hospitals segment is expected to remain the attractive, and is estimated to account for 3/10 share of the North America market value by 2031 end.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: